Search for Clinical Trial Results
IgA Nephropathy - 30 Studies Found
Status | Study |
Completed |
Study Name: IgA Nephropathy, Lymphocyte Homing and IgA Class Switch Condition: IgA Nephropathy Date: 2013-01-18 Interventions: Other: blood test |
Completed |
Study Name: The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease Condition: Primary IgA Nephropathy Date: 2012-07-25 Interventions:
|
Withdrawn |
Study Name: BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy Condition: IgA Nephropathy Date: 2014-01-29 Interventions:
|
Not yet recruiting |
Study Name: Integrative Medicine of IgA Nephropathy Condition: Primary IgA Nephropathy Date: 2015-11-17 Interventions:
|
Terminated |
Study Name: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy Condition: IgA Nephropathy Date: 2006-04-24 Interventions:
|
Active, not recruiting |
Study Name: BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration Condition: IgA Nephropathy Date: 2014-02-12 Interventions:
|
Completed |
Study Name: Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy Condition: IgA Nephropathy Date: 2007-10-29 Interventions:
|
Completed |
Study Name: Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers Condition: IgA Nephropathy Date: 2010-11-08 Interventions: Drug: Calcitriol Calcitriol(1,25-dihydroxycholecalciferol, vitamin D3 analog)0.25 μg per day |
Recruiting |
Study Name: Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy Condition: IgA Nephropathy Date: 2016-11-24 Interventions:
|
Completed |
Study Name: Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy Condition: IgA Nephropathy Date: 2015-08-17 Interventions: Biological: blood sample dosage of anti-hinge region antibodies |